Biofrontera Inc. provided earnings guidance for the fiscal year of 2022. For the period, the company expects total revenues to increase by at least 30% compared with 2021, including typical seasonal strength in the first and fourth quarters.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.03 USD | +1.98% | -1.90% | -62.82% |
05-16 | Transcript : Biofrontera Inc., Q1 2024 Earnings Call, May 16, 2024 | |
05-15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.82% | 5.24M | |
+40.73% | 739B | |
+31.57% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.34% | 240B | |
+9.44% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- BFRI Stock
- News Biofrontera Inc.
- Biofrontera Inc. Provides Earnings Guidance for the Fiscal Year of 2022